Kardiologie up2date 2016; 12(03): 233-236
DOI: 10.1055/s-0042-113147
Hotline – Thrombozyten und Gerinnungssystem bei kardiovaskulären Erkrankungen
© Georg Thieme Verlag KG Stuttgart · New York

Periinterventionelle Antikoagulation bei der Vorhofflimmerablation

David Heinzmann
Peter Seizer
Further Information

Publication History

Publication Date:
29 September 2016 (online)


Ablation of atrial fibrillation is associated with a significant risk of thromboembolism and bleeding. Whereas continuous application of vitamin K antagonists seem to be feasible, the increasing use of direct oral anticoagulants (DOAKs) in patients with atrial fibrillation moves this topic in a novel focus for interventional electrophysiologists. The article describes current use of oral anticoagulants for atrial fibrillation ablation.